Oral Session 1-12A Transplant outcomes (1)

[OS1-12A-6] Impact of dose reduction of posttransplant cyclophosphamide on RIC based HLA-haploidentical PBSCT

Junichi Sugita¹, Shuichi Ota², Tomohiko Kamimura³, Eijiro Omoto⁴, Takashi Kuroha⁵, Keitaro Matsuo⁶, Koichi Akashi⁷, Shuichi Taniguchi⁸, Mine Harada⁹, Takanori Teshima¹ (1.Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan, 2.Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 3.Hematology, Harasanshin Hospital, Fukuoka, Japan, 4.Hematology, Yamagata Prefectural Central Hospital, Yamagata, Japan, 5.Hematology, Nagaoka Red Cross Hospital, Nagaoka, Japan, 6.Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan, 7.Hematology/Oncology, Kyushu University Hospital, Fukuoka, Japan, 8.Hematology, Toranomon Hospital, Tokyo, Japan, 9.Karatsu Higashimatsuura Medical Center, Karatsu, Japan)